The Department of Defense Ovarian Cancer Clinical Translational Leverage Award aims to leverage human-based ovarian cancer resources in translational research. This grant supports early-phase clinical trials and correlative studies to explore high-impact research ideas and unmet needs in ovarian cancer. Applicants are required to provide preliminary data. The closing date for this grant is August 27, 2014.
Opportunity ID: 253891
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | W81XWH-14-OCRP-CTLA |
| Funding Opportunity Title: | DoD Ovarian Cancer Clinical Translational Leverage Award |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement Grant |
| Category of Funding Activity: | Science and Technology and other Research and Development |
| Category Explanation: | – |
| Expected Number of Awards: | 2 |
| Assistance Listings: | 12.420 — Military Medical Research and Development |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 15, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Aug 27, 2014 |
| Current Closing Date for Applications: | Aug 27, 2014 |
| Archive Date: | Sep 26, 2014 |
| Estimated Total Program Funding: | $800,000 |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
| Additional Information on Eligibility: | – |
Additional Information
| Agency Name: | Dept. of the Army — USAMRAA |
| Description: | The intent of the OCRP Clinical Translational Leverage Award mechanism is to support leveraging of human-based ovarian cancer resources in translational research. This award supports early-phase, proof-of-principle clinical trials and correlative studies (retrospective and prospective) to investigate high-impact research ideas or unmet needs in ovarian cancer. Preliminary data are required. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
301-682-5507; help@eBRAP.org
Email:help@eBRAP.org |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 253891 Full Announcement-1 -> w81xwh-14-ocrp-ctla.pdf
Folder 253891 Full Announcement-1 -> ocrp fy14 ctla ind documentation form_gg.pdf
Packages
| Agency Contact Information: | 301-682-5507; help@eBRAP.org Email: help@eBRAP.org |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 12.420 | PKG00195286 | Apr 15, 2014 | Aug 27, 2014 | View |
Package 1
Mandatory forms
253891 RR_SF424_2_0-2.0.pdf
253891 RR_Budget_1_3-1.3.pdf
253891 RR_KeyPersonExpanded_2_0-2.0.pdf
253891 PerformanceSite_2_0-2.0.pdf
Optional forms
253891 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
